Opus Genetics (IRD) Amortizatization of Intangibles (2018 - 2020)
Opus Genetics (IRD) reported Amortizatization of Intangibles of -$1000.0 for Q4 2020, down 100.11% year-over-year from $927230.0 in Q1 2020, and down 112.5% quarter-over-quarter from $8000.0 in Q3 2020.
Opus Genetics (IRD) Amortizatization of Intangibles (2018 - 2020) Analysis & Trends
Opus Genetics (IRD) has 3 years of Amortizatization of Intangibles data on file, last reported at -$1000.0 in Q4 2020.
- Amortizatization of Intangibles for Q4 2020 came in at -$1000.0, down 100.11% year-over-year; the trailing twelve-month figure through Sep 2021 was -$1000.0 (down 100.06% YoY), and the FY2020 annual result was $873000.0, down 13.91% from the prior year.
- Amortizatization of Intangibles declined to -$1000.0 in Q4 2020 per IRD's latest filing, from $8000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $927230.0 in Q4 2019 and troughed at -$14907.0 in Q1 2018.
- A 3-year average of $154812.4 and a median of $13249.5 in 2019 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2019 and 2020: Amortizatization of Intangibles surged 22491.45% in 2019, then slumped 100.11% in 2020.
- A 3-year view of Amortizatization of Intangibles shows it stood at -$4141.0 in 2018, then soared by 22491.45% to $927230.0 in 2019, then tumbled by 100.11% to -$1000.0 in 2020.
- Business Quant data shows IRD's Amortizatization of Intangibles at -$1000.0 in Q4 2020, $8000.0 in Q3 2020, and $500000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Opus Genetics | 355.39 Mn | 295.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -1,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Sep 30, 2020 | 8,000.00 |
| Sep 30, 2020 | 8,000.00 |
| Jun 30, 2020 | 500,000.00 |
| Jun 30, 2020 | 500,000.00 |
| Mar 31, 2020 | 376,000.00 |
| Mar 31, 2020 | 376,000.00 |
| Dec 31, 2019 | 927,230.00 |
| Dec 31, 2019 | 927,230.00 |
| Sep 30, 2019 | 30,751.00 |
| Sep 30, 2019 | 30,751.00 |
| Jun 30, 2019 | 37,520.00 |
| Jun 30, 2019 | 37,520.00 |
| Mar 31, 2019 | 18,499.00 |
| Mar 31, 2019 | 18,499.00 |
| Dec 31, 2018 | -4,141.00 |
| Dec 31, 2018 | -4,141.00 |
| Sep 30, 2018 | -8,606.00 |
| Sep 30, 2018 | -8,606.00 |